Literature DB >> 11281470

Exploration of cyclical changes in memory and mood in postmenopausal women taking sequential combined oestrogen and progestogen preparations.

V Natale1, P Albertazzi, M Zini, R Di Micco.   

Abstract

OBJECTIVE: To investigate the effect of progesterone on cognitive function, mood, sleep quality and libido when added to oestrogen in sequential combined hormonal replacement therapy regimens.
DESIGN: Observational study over three hormonal replacement therapy cycles.
SETTING: Menopause Centre of Ospedale Maternità, Bologna, Italy. POPULATION: Twenty-three postmenopausal women with an average of 70 months of amenorrhoea (range 12 to 234 months) on different sequential combined hormonal replacement therapy regimen for an average of 15 months (range 3-48) months.
METHODS: Psychological testing for memory, mood, sleep quality and libido during the oestrogen only part of the cycle compared with the oestrogen-progestogen part of the cycle.
RESULTS: Twenty women completed the six visits of the trial. The addition of progestogens to oestrogen appeared to benefit memory (P < 0.01) but worsened mood (P < 0.005). There was no evidence of change in other parameters such as sleep quality or libido.
CONCLUSION: The addition of progestogens improved memory above what was obtained with oestrogen alone. This effect did not depend on an improvement of mood since the latter worsened during the progestogenic phase of an hormonal replacement therapy cycle. Progestogen added to oestrogen did not significantly influence sleep or libido.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11281470     DOI: 10.1111/j.1471-0528.2001.00070.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  7 in total

Review 1.  The role of ovarian hormones in preserving cognition in aging.

Authors:  Jeri S Janowsky
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 2.  The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review.

Authors:  Ronald F Zec; Mehul A Trivedi
Journal:  Neuropsychol Rev       Date:  2002-06       Impact factor: 7.444

3.  Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy.

Authors:  Maria Pia Rogines-Velo; Amy E Heberle; Hadine Joffe
Journal:  Menopause       Date:  2012-04       Impact factor: 2.953

4.  Postmenopausal hormones and sleep quality in the elderly: a population based study.

Authors:  Gregory J Tranah; Neeta Parimi; Terri Blackwell; Sonia Ancoli-Israel; Kristine E Ensrud; Jane A Cauley; Susan Redline; Nancy Lane; Misti L Paudel; Teresa A Hillier; Kristine Yaffe; Steven R Cummings; Katie L Stone
Journal:  BMC Womens Health       Date:  2010-05-04       Impact factor: 2.809

5.  The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.

Authors:  Allison Kimball; Laura E Dichtel; Maren B Nyer; David Mischoulon; Lauren B Fisher; Cristina Cusin; Christina M Dording; Nhi-Ha Trinh; Albert Yeung; Melanie S Haines; Joshua C Sung; Graziano Pinna; Ann M Rasmusson; Linda L Carpenter; Maurizio Fava; Anne Klibanski; Karen Klahr Miller
Journal:  Psychoneuroendocrinology       Date:  2019-11-14       Impact factor: 4.905

6.  Interactive Effects of Dopamine Baseline Levels and Cycle Phase on Executive Functions: The Role of Progesterone.

Authors:  Esmeralda Hidalgo-Lopez; Belinda Pletzer
Journal:  Front Neurosci       Date:  2017-07-13       Impact factor: 4.677

Review 7.  Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence.

Authors:  Maria Garefalakis; Martha Hickey
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.